Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Description of alloHSCT subjects and documentation of complement deposition in cutaneous and bone marrow microvasculature in those with and without TMA.

Data availability

Data used and/or analyzed during this study are available from the corresponding author on reasonable request.


  1. Young JA, Pallas CR, Knovich MA. Transplant-associated microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis. Bone Marrow Transpl. 2021;56:1805–17.

    Article  Google Scholar 

  2. Chapin J, Shore T, Forsberg P, Desman G, Van Besien K, Laurence J. Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. Clin Adv Hematol Oncol. 2014;12:565–73.

    PubMed  Google Scholar 

  3. Horvath O, Kallay K, Csuka DF, Mezo B, Sinkovits G, Kassa C, et al. Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation. Biol Blood Marrow Transpl. 2018;24:989–96.

    CAS  Article  Google Scholar 

  4. Jodele S, Dandoy CE, Lane A, Laskin BL, Teusink-Cross A, Myers KC, et al. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated wirth eculizumab. Blood. 2020;135:1049–57.

    PubMed  PubMed Central  Google Scholar 

  5. Elhadad S, Chapin J, Copertino D, Van Besien K, Ahamed J, Laurence J. MASP2 levels are elevated in thrombotic microangiopathies: Association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. Clin Exp Immunol. 2021;203:96–104.

    CAS  Article  Google Scholar 

  6. Wall SA, Zhao Q, Yearsley M, Blower L, Agyeman A, Ranganathan P, et al. Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD. Blood Adv. 2018;2:2619–28.

    CAS  Article  Google Scholar 

  7. Qi J, Wang J, Chen J, Su J, Tang Y, Wu X, et al. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation. Ann Hematol. 2017;96:1849–55.

    CAS  Article  Google Scholar 

  8. Magro CM, Momtahen S, Mulvey JJ, Yassin AH, Kaplan RB, Laurence JC. The role of skin biopsy in the diagnosis of atypical hemolytic uremic syndrome. Am J Dermatopathol. 2015;37:349–59.

    Article  Google Scholar 

  9. Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1–13.

    CAS  Article  Google Scholar 

  10. Triebwasser M Excessive complement activation due to genetic haploinsufficiency of regulators in multiple human diseases. Arts & Sciences Electronic Theses and Dissertations. 2015:427.

  11. Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, et al. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2014;25:55–64.

    CAS  Article  Google Scholar 

  12. Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC, et al. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood. 2016;127:989–96.

    CAS  Article  Google Scholar 

  13. Khaled SK, Claes K, Goh YT, Kwong YL, Leung N, Mendrek W, et al. Narsoplimab, a mannan-binding lectin-associated serine protease-2 inhibitor, for the treatment of adult hematopoietic stem-cell transplantation-associated thrombotic microangiopathy. J Clin Oncol. 2022;

  14. Martinez-Munoz ME, Fores R, Lario A, Bautista G, Bueno JL, de Miguel C, et al. Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy. Bone Marrow Transpl. 2019;54:142–5.

    CAS  Article  Google Scholar 

Download references


We thank Daniel Greenberg, Sharon Barouk-Fox, Paula Bertram, Beatriz Lorenzo, Levi Y. Elhadad, and Yuzhou Zhang in the laboratory of Dr. Richard Smith of the University of Iowa for expert technical work. This work was supported by funds from: Omeros (JL), Jazz Pharmaceuticals (JL), and the NIH (RO1 HL148123 and HL123605 (JA), and R01 GM099111 (JPA.) and U54 HL112303 (JPA and EDOR)).

Author information

Authors and Affiliations



JL conceived the study and wrote the paper. SE, KVB, AC, EDOR, EO, and JPA edited the manuscript and provided important insights. JPA and EDOR performed the genetic analyses. CM performed the skin biopsy analyses. AC performed the bone marrow analyses. SE, DC, SG, and JA performed select studies, provided insights and help edit the manuscript. SE, DC, and SG did the statistical analyses. WR, JG, and JC coordinated patient studies. LBR, UG, SM, and TS treated these patients and obtained the blood and bone marrow aspirate samples.

Corresponding author

Correspondence to Jeffrey Laurence.

Ethics declarations

Competing interests

JL has received a research grant and JL and UG have received speaker fees from Alexion. JL and SM have current research grants from Omeros, Inc., and JL from Jazz Pharmaceuticals. These entities did not have input in the study design, analysis, manuscript preparation, or decision to submit for publication. The remaining authors declare no competing financial interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Elhadad, S., Chadburn, A., Magro, C. et al. C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone Marrow Transplant (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


Quick links